The primary role of the hyper-responsive islet beta-cell in severe insulin resistant type 2 diabetes

Researchers

Grant status

Active

Grant start date

08/04/2021

Grant funding

  • 2021: $280,726 from Canberra Health Services

Updated:  19 May 2024 / Responsible Officer:  Director (Research Services Division) / Page Contact:  Researchers